138 related articles for article (PubMed ID: 38118008)
1. The Reality of Antimicrobial Resistance and Antibiotic Usage Data in Asia: The CAPTURA Experience.
Leslie T; Parry C; Ondoa P; Walsh T; Moore C; Poudyal N; Marks F; Gordon NC
Clin Infect Dis; 2023 Dec; 77(Suppl 7):S497-S499. PubMed ID: 38118008
[TBL] [Abstract][Full Text] [Related]
2. Effective Stakeholder Engagement for Collation, Analysis and Expansion of Antimicrobial Resistance (AMR) Data: A CAPTURA Experience.
Poudyal N; Holm M; Joh HS; Gautam S; Sujan MJ; Kwon SY; Sahikh A; Shaw A; Gallagher P; Prifti K; Cho A; Chi KK; Aboushady AT; MacWright WR; Stelling J; Marks F
Clin Infect Dis; 2023 Dec; 77(Suppl 7):S519-S527. PubMed ID: 38118005
[TBL] [Abstract][Full Text] [Related]
3. Capturing Data on Antimicrobial Resistance Patterns and Trends in Use in Regions of Asia (CAPTURA).
Holm M; MacWright WR; Poudyal N; Shaw AG; Joh HS; Gallagher PF; Kim JH; Shaikh AT; Seo HJ; Kwon SY; Prifti K; Dolabella B; Taylor BEW; Yeats C; Aanensen DM; Stelling J; Marks F
Clin Infect Dis; 2023 Dec; 77(Suppl 7):S500-S506. PubMed ID: 38118015
[TBL] [Abstract][Full Text] [Related]
4. CAPTURA Regional Workshop Proceedings (28-30 June 2022, Virtual).
Joh HS; Dolabella B; Early E; Stelling J; Ak G; Upadhyaya MK; Rahman A; Chuki P; MacWright WR; Ondoa P; Sarkar S; Moore C; Holm M; Leslie T; Zellweger RM; Paing G; Kwon SY; Marks F; Poudyal N
Clin Infect Dis; 2023 Dec; 77(Suppl 7):S536-S542. PubMed ID: 38118006
[TBL] [Abstract][Full Text] [Related]
5. Methodological Approach to Identify and Expand the Volume of Antimicrobial Resistance (AMR) Data in the Human Health Sector in Low- and Middle-Income Countries in Asia: Implications for Local and Regional AMR Surveillance Systems Strengthening.
Joh HS; Yeats C; Shaw A; Poudyal N; Gallagher P; Kim JH; Shaikh A; Seo HJ; Chi KK; Prifti K; Cho A; Sujan MJ; Eraly E; Pham KD; Shrestha S; Aboushady AT; Pak G; Jang G; Park EL; Seo HW; Abudahab K; Taylor BEW; Clark A; Dolabella B; Yoon H; Han J; Kwon SY; Marks F; Stelling J; Aanensen DM; MacWright WR; Holm M
Clin Infect Dis; 2023 Dec; 77(Suppl 7):S507-S518. PubMed ID: 38118007
[TBL] [Abstract][Full Text] [Related]
6. Recording and Reporting of Antimicrobial Resistance (AMR) Priority Variables and Its Implication on Expanding Surveillance Sites in Nepal: A CAPTURA Experience.
Maharjan S; Gallagher P; Gautam M; Joh HS; Sujan MJ; Aboushady AT; Kwon SY; Gautam S; Upadhyaya MK; Jha R; Acharya J; MacWright WR; Marks F; Stelling J; Poudyal N
Clin Infect Dis; 2023 Dec; 77(Suppl 7):S560-S568. PubMed ID: 38118014
[TBL] [Abstract][Full Text] [Related]
7. Key Recommendations for Antimicrobial Resistance Surveillance: Takeaways From the CAPTURA Project.
Aboushady AT; Sujan MJ; Pham K; Clark A; Marks F; Holm M; Joh HS; Poudyal N; Stelling J
Clin Infect Dis; 2023 Dec; 77(Suppl 7):S581-S587. PubMed ID: 38118016
[TBL] [Abstract][Full Text] [Related]
8. Considerations for Expanding Antimicrobial Resistance Surveillance Networks.
Gallagher P; Shaw A; Bhandari A; Poudyal N; Holm M; MacWright WR
Clin Infect Dis; 2023 Dec; 77(Suppl 7):S578-S580. PubMed ID: 38118012
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial Resistance Surveillance Methods in Bangladesh: Present and Way Forward.
Sujan MJ; Habib ZH; Rahman A; Rizvi SMS; Barua HT; Aboushady AT; Hasnat MA; Rasul SBG; Joh HS; Prifti K; Chi KK; Kwon SY; Clark A; Gautam S; Holm M; Marks F; Stelling J; Shaw A; Poudyal N
Clin Infect Dis; 2023 Dec; 77(Suppl 7):S549-S559. PubMed ID: 38118018
[TBL] [Abstract][Full Text] [Related]
10. Utility and Evaluation of Applied Project Management Processes Within a Large Multicountry Health Systems Development Project Conducted During the Coronavirus Disease 2019 (COVID-19) Pandemic.
Kwon SY; Gautam S; Poudel K; Banneheke H; Ferreira D; Gautam M; Hau'ofa M; Mahmood N; Phommalad B; Sujan MJ; Yangzom P; Joh HS; Shaw A; Dolabella B; Seo HJ; Kim JH; Gallagher P; MacWright WR; Poudyal N; Marks F; Holm M
Clin Infect Dis; 2023 Dec; 77(Suppl 7):S543-S548. PubMed ID: 38118010
[TBL] [Abstract][Full Text] [Related]
11. Antimicrobial Resistance Surveillance in Low- and Middle-Income Countries: Progress and Challenges in Eight South Asian and Southeast Asian Countries.
Gandra S; Alvarez-Uria G; Turner P; Joshi J; Limmathurotsakul D; van Doorn HR
Clin Microbiol Rev; 2020 Sep; 33(3):. PubMed ID: 32522747
[TBL] [Abstract][Full Text] [Related]
12. Global diversity and antimicrobial resistance of typhoid fever pathogens: Insights from a meta-analysis of 13,000
Carey ME; Dyson ZA; Ingle DJ; Amir A; Aworh MK; Chattaway MA; Chew KL; Crump JA; Feasey NA; Howden BP; Keddy KH; Maes M; Parry CM; Van Puyvelde S; Webb HE; Afolayan AO; Alexander AP; Anandan S; Andrews JR; Ashton PM; Basnyat B; Bavdekar A; Bogoch II; Clemens JD; da Silva KE; De A; de Ligt J; Diaz Guevara PL; Dolecek C; Dutta S; Ehlers MM; Francois Watkins L; Garrett DO; Godbole G; Gordon MA; Greenhill AR; Griffin C; Gupta M; Hendriksen RS; Heyderman RS; Hooda Y; Hormazabal JC; Ikhimiukor OO; Iqbal J; Jacob JJ; Jenkins C; Jinka DR; John J; Kang G; Kanteh A; Kapil A; Karkey A; Kariuki S; Kingsley RA; Koshy RM; Lauer AC; Levine MM; Lingegowda RK; Luby SP; Mackenzie GA; Mashe T; Msefula C; Mutreja A; Nagaraj G; Nagaraj S; Nair S; Naseri TK; Nimarota-Brown S; Njamkepo E; Okeke IN; Perumal SPB; Pollard AJ; Pragasam AK; Qadri F; Qamar FN; Rahman SIA; Rambocus SD; Rasko DA; Ray P; Robins-Browne R; Rongsen-Chandola T; Rutanga JP; Saha SK; Saha S; Saigal K; Sajib MSI; Seidman JC; Shakya J; Shamanna V; Shastri J; Shrestha R; Sia S; Sikorski MJ; Singh A; Smith AM; Tagg KA; Tamrakar D; Tanmoy AM; Thomas M; Thomas MS; Thomsen R; Thomson NR; Tupua S; Vaidya K; Valcanis M; Veeraraghavan B; Weill FX; Wright J; Dougan G; Argimón S; Keane JA; Aanensen DM; Baker S; Holt KE;
Elife; 2023 Sep; 12():. PubMed ID: 37697804
[TBL] [Abstract][Full Text] [Related]
13. Implementation of the World Health Organization Global Antimicrobial Resistance Surveillance System in Uganda, 2015-2020: Mixed-Methods Study Using National Surveillance Data.
Nabadda S; Kakooza F; Kiggundu R; Walwema R; Bazira J; Mayito J; Mugerwa I; Sekamatte M; Kambugu A; Lamorde M; Kajumbula H; Mwebasa H
JMIR Public Health Surveill; 2021 Oct; 7(10):e29954. PubMed ID: 34673531
[TBL] [Abstract][Full Text] [Related]
14. How can lessons from the COVID-19 pandemic enhance antimicrobial resistance surveillance and stewardship?
Walia K; Mendelson M; Kang G; Venkatasubramanian R; Sinha R; Vijay S; Veeraraghavan B; Basnyat B; Rodrigues C; Bansal N; Ray P; Mathur P; Gopalakrishnan R; Ohri VC
Lancet Infect Dis; 2023 Aug; 23(8):e301-e309. PubMed ID: 37290476
[TBL] [Abstract][Full Text] [Related]
15. Antimicrobial resistance landscape and COVID-19 impact in Egypt, Iraq, Jordan, and Lebanon: A survey-based study and expert opinion.
Bizri AR; El-Fattah AA; Bazaraa HM; Al Ramahi JW; Matar M; Ali RAN; El Masry R; Moussa J; Abbas AJA; Aziz MA
PLoS One; 2023; 18(7):e0288550. PubMed ID: 37498951
[TBL] [Abstract][Full Text] [Related]
16. The burden of bacterial antimicrobial resistance in the WHO European region in 2019: a cross-country systematic analysis.
European Antimicrobial Resistance Collaborators
Lancet Public Health; 2022 Nov; 7(11):e897-e913. PubMed ID: 36244350
[TBL] [Abstract][Full Text] [Related]
17. Impact of the COVID-19 pandemic on the surveillance, prevention and control of antimicrobial resistance: a global survey.
Tomczyk S; Taylor A; Brown A; de Kraker MEA; El-Saed A; Alshamrani M; Hendriksen RS; Jacob M; Löfmark S; Perovic O; Shetty N; Sievert D; Smith R; Stelling J; Thakur S; Vietor AC; Eckmanns T;
J Antimicrob Chemother; 2021 Oct; 76(11):3045-3058. PubMed ID: 34473285
[TBL] [Abstract][Full Text] [Related]
18. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.
Antimicrobial Resistance Collaborators
Lancet; 2022 Feb; 399(10325):629-655. PubMed ID: 35065702
[TBL] [Abstract][Full Text] [Related]
19. Antimicrobial resistance in low- and middle-income countries: current status and future directions.
Sulis G; Sayood S; Gandra S
Expert Rev Anti Infect Ther; 2022 Feb; 20(2):147-160. PubMed ID: 34225545
[TBL] [Abstract][Full Text] [Related]
20. Estimating the subnational prevalence of antimicrobial resistant Salmonella enterica serovars Typhi and Paratyphi A infections in 75 endemic countries, 1990-2019: a modelling study.
GRAM Typhoid Collaborators
Lancet Glob Health; 2024 Mar; 12(3):e406-e418. PubMed ID: 38365414
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]